Page 72 - DP Vol 20 No 4 HR
P. 72

NEWS


                                                                   BOMBAY HIGH COURT ISSUES NOTICE ON PIL SEEKING
           Government bans 156 medicines                           ACTION AGAINST DENTAL PRACTITIONERS FOR
           including antibiotics and painkillers
                                                                   PERFORMING HAIR TRANSPLANT SURGERIES

           In a significant move aimed at safeguarding public health, the
           Indian government has banned 156 fixed-dose combination (FDC)   The Bombay High Court has issued a notice on a Public Interest
           drugs, including a variety of antibiotics and painkillers routinely   Litigation (PIL) petition, which seeks action against the Oral and
           prescribed by dentists also.  The ban list includes “Aceclofenac   Maxillofacial  Surgeons  performing  Aesthetic  and  Hair  Transplant
           50mg + Paracetamol 125mg tablet.” This is one of the popular   surgeries. A division bench issued notice to the respondents to the
           combinations of pain-relieving medicines manufactured by   petition after it was informed that the National Dental Commission
           leading pharmaceutical companies. The list also includes   of India (NDCI) as mandated under the National Dental Commission
                                           Mefenamic Acid +                                        Act,  2023,  has  not  yet
                                           Paracetamol Injection,                                  been constituted by the
                                           and the combination of                                  Central  Government.  The
                                           Paracetamol, Tramadol,                                  petitioners  -  Dynamic
                                           Taurine and Caffeine
                                           as well as Paracetamol                                  Dermatologist  and  Hair
                                           + Phenylephrine                                         Transplant  Association
                                           Hydrochloride +                                         filed  a  PIL  petition
                                           Chlorpheniramine                                        challenging  the  guidelines
           Maleate.                                                issued by the Dental Council of India (DCI) on December 6, 2022,
              The Central government is satisfied that the use of these   permitting the Oral and Maxillofacial Surgeons to practice Aesthetic
           Fixed Dose Combination drugs is likely to involve risk to human   and Hair Transplant surgery. The PIL raises concerns over the growing
           beings whereas safer alternatives to the said drug are available,”   number of complaints from dermatologists, hair transplant surgeons,
           as per the notification. It said that the matter was examined by   and the public regarding dental practitioners engaging in these
           an Expert Committee appointed by the Centre, which considered   specialised fields without adequate expertise. The petitioner therefore
           these FDCs as “irrational”. The ban is expected to impact major   has sought a direction to the concerned authorities to withdraw the
           pharmaceutical companies, including Sun Pharmaceuticals,
           Cipla, Dr. Reddy’s Laboratories, Torrent Pharmaceuticals, and   December 6, 2022 guidelines. The plea also seeks action against dental
           Alkem Laboratories.                                     practitioners, who are putting up advertisements for performing hair
                                                                   transplants.




           FMS Dental launches Neuromuscular Dentistry speciality




           Hyderabad-based FMS Dental has introduced a speciality in
           neuromuscular dentistry. Neuromuscular Dentistry not only involves
           temporomandibular joint (TMJ) disorders and jaw movement issues
           but also includes orofacial pain (OFP) disorders like neuropathic and
           neurovascular pain disorders, headaches and sleep disorders.
           Dr  Parthasarathi  Reddy, Founder and Chairman, FMS Dental
           Hospitals said, “Neuromuscular dentistry is a relatively new field in
           dentistry, in which our dedicated, well trained and highly experienced
           team, excel. Our team has received international training and has
           accumulated extensive experience over many years, positioning them
           at the forefront of treating temporomandibular joint (TMJ) disorders
           and orofacial pain. Through their commitment and expertise, our
           team has developed and refined proven treatment protocols that have
           already benefited hundreds of patients.”
           Symptoms of OFP can vary widely, encompassing headaches, neck   to diagnose and treat neuromuscular disorders of the face. EMG
           pain, ear pain, dental discomfort, facial burning or stabbing sensations   sensors, jaw tracker,  BioJVA (Joint Vibrational Analysis), Ultra Low-
           and jaw pain. Additionally, atypical symptoms such as tinnitus (ringing   Frequency TENS unit, ultrasound therapy and low-level laser therapy
           in the ears), dizziness, muscle incoordination or unusual itching and   are used to detect and treat neuromuscular disorders. The T-Scan
           tingling in the head and neck may also occur.          system provides detailed dynamic occlusal measurements, assessing
              At FMS Dental, advanced technologies and techniques are utilized   force distribution on individual teeth and overall bite stability.

           72  Dental Practice I July-August 2024 I Vol 20 No 4
   67   68   69   70   71   72   73   74   75   76   77